![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Tacrolimus monohydrate, Process B, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-345 - Rev 00
This Chemical Type CEP, issued on March 28, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2244 associated with this CEP further emphasizes